Beaudry, Michael

Cote, Robert

Crimmins, Denis

Davis, Stephen

De Bleecker, Jan

Deceuninck, Frans

Dimmitt, Simon

Donnan, Geoffrey

Frayne, Judith

Freilich, David

Gillies, David

Gomes Fernandes, Jefferson

Hoyte, Keith

Lebrun, Louise Helene

Matamala, Gonzalo

Mikocki, Johannes

Norris, John

Robberecht, Wim

Sahlas, Demetrios J.

Schmidauer, Christoph

Schmidt, Reinhold

Selchen, Daniel

Shuaib, Ashfaq

Simard, Denis

Spence, David

Tack, Phillippe

Teal, Philip

Thijs, Vincent

Winger, Michael

English

Scholarship@Western

Western University Scholarship@Western Department of Medicine Publications Medicine Department 2-10-2004 Erratum: Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (Cerebrovascular Diseases (2003) 16 (389-395)) Denis Crimmins Central Coast Neurosciences Research Stephen Davis Royal Melbourne Hospital Simon Dimmitt Royal Perth Hospital Geoffrey Donnan Austin Health Judith Frayne The Alfred See next page for additional authors Follow this and additional works at: https://ir.lib.uwo.ca/medpub Citation of this paper: Crimmins, Denis; Davis, Stephen; Dimmitt, Simon; Donnan, Geoffrey; Frayne, Judith; Freilich, David; Gillies, David; Mikocki, Johannes; Schmidauer, Christoph; Schmidt, Reinhold; De Bleecker, Jan; Deceuninck, Frans; Tack, Phillippe; Thijs, Vincent; Robberecht, Wim; Gomes Fernandes, Jefferson; Beaudry, Michael; Cote, Robert; Hoyte, Keith; Lebrun, Louise Helene; Sahlas, Demetrios J.; Norris, John; Selchen, Daniel; Shuaib, Ashfaq; Simard, Denis; Spence, David; Teal, Philip; Winger, Michael; and Matamala, Gonzalo, "Erratum: Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (Cerebrovascular Diseases (2003) 16 (389-395))" (2004). Department of Medicine Publications. 293. https://ir.lib.uwo.ca/medpub/293 Authors Denis Crimmins, Stephen Davis, Simon Dimmitt, Geoffrey Donnan, Judith Frayne, David Freilich, David Gillies, Johannes Mikocki, Christoph Schmidauer, Reinhold Schmidt, Jan De Bleecker, Frans Deceuninck, Phillippe Tack, Vincent Thijs, Wim Robberecht, Jefferson Gomes Fernandes, Michael Beaudry, Robert Cote, Keith Hoyte, Louise Helene Lebrun, Demetrios J. Sahlas, John Norris, Daniel Selchen, Ashfaq Shuaib, Denis Simard, David Spence, Philip Teal, Michael Winger, and Gonzalo Matamala This article is available at Scholarship@Western: https://ir.lib.uwo.ca/medpub/293 ErratumPublished online: November 21, 2003ABCFax + 41 61 306 12 34E-Mail karger@karger.chwww.karger.com© 2004 S. Karger AG, BaselAccessible online at:www.karger.com/cedCerebrovasc Dis 2004;17:91–92Design and Baseline Characteristics of theStroke Prevention by Aggressive Reductionin Cholesterol Levels (SPARCL) Study(Cerebrovasc Dis 2003;16:389–395)The SPARCL InvestigatorsThe publishers have been informed by the authors that the list ofparticipating centers of the above mentioned article was not the mostrecent update. In addition, the members of the SPARCL PublicationSub-Committee were left out. The correct lists are published below.The SPARCL Publication Sub-CommitteeWayne M. Clark (Oregon Stroke Center, Portland, Oreg., USA);Antonio Dávalos (Hospital Josep Trueta, Girona, Spain); Larry B.Goldstein (Duke University Medical Center, Durham, N.C., USA);Markku Kaste (Helsinki University Hospital, Helsinki, Finland);Lawrence Leiter (St. Michael’s Health Center, Toronto, Ontario,Canada); Justin Zivin (University of California San Diego, San Die-go, Calif., USA). Henrik Sillesen (Gentofte Hospital, University ofCopenhagen, Copenhagen, Denmark).The SPARCL InvestigatorsAustralia: Denis Crimmins (Central Coast Neurosciences Re-search, Gosford); Stephen Davis (Royal Melbourne Hospital, Park-ville); Simon Dimmitt (Royal Perth Hospital, Perth); Geoffrey Don-nan (Austin & Repatriation Medical Centre, Heidelberg); JudithFrayne (Alfred Hospital, Prahran); David Freilich (Western Hospi-tal, Footscray); David Gillies (Prince of Wales Hospital, Randwick).Austria: Johannes Mikocki (Wilhelminenspital der Stadt Wien,Wien); Christoph Schmidauer (Leopold-Franzens-Universität, Inns-bruck); Reinhold Schmidt (Universitätsklinik für Neurologie, Graz).Belgium: Jan De Bleecker (AZ St. Lucas, Gent); Frans Deceuninck(Kliniek O.L.V. van Lourdes, Waregem); Phillippe Tack (St. AndriesZiekenhuis, Tielt); Vincent Thijs, Wim Robberecht (University Hos-pital Gasthuisberg, Leuven). Brazil: Jefferson Gomes Fernandes(Sao Lucas Hospital, Porto Alegre). Canada: Michael Beaudry (Com-plexe Hospitalier de la Sagamie, Chicoutimi, Quebec); Robert Cote(Montreal General Hospital, Montreal, Quebec); Keith Hoyte(Foothills Hospital, Calgary, Alberta); Louise-Helene Lebrun (Hôpi-tal Notre-Dame du CHUM, Montreal, Quebec); Demetrios J. Sahlas,John Norris (Sunnybrook Stroke Research Unit, Toronto, Ontario);Daniel Selchen (Trillium Health Centre, Mississauga, Ontario); Ash-faq Shuaib (University of Alberta Hospital, Edmonton, Alberta);Denis Simard (Hospital L’Enfant Jesus, Quebec City, Quebec); Da-vid Spence (Seibens-Drake/Robarts Research Institute, London, On-tario); Philip Teal (Vancouver General Hospital, Vancouver, BritishColumbia); Michael Winger (Windsor Regional Hospital, Tecumseh,Ontario). Chile: Gonzalo Matamala, Arturo Jaramillo (HospitalNaval Almirante Nef, Vina Del Mar). Czech Republic: Renata Cif-kova (Institute for Clinical and Experimental Medicine, Praha); Zby-nek Kalita (Bata Hospital, Zlin); Ivan Rektor (Masaryk University,St. Ann’s Hospital, Brno); Hana Rosolova (Faculty Hospital Pilsen,Pilsen); Roman Stipal (Faculty Hospital Ostrava, Ostrava-Poruba);Daniel Vaclavik (Blessed Mary Anthony Hospital, Ostrava). Den-mark: Gudrun Boysen (Bispebjerg Hospital, Copenhagen NV); HelleIversen, Allan R. Anderson (Glostrup Hospital, Glostrup); HenrikSillesen (Gentofte Hospital, Copenhagen). Finland: Matti Hillbom(Oulu University Hospital, Oys); Markku Kaste (Helsinki UniversityHospital, Helsinki); Heikki Numminen (South Karelia Central Hos-pital, Lappeenranta); Antero Pilke (Kymenlaakso Central Hospital,Kotka); Annikki Salmivaara, Osmo Pammo (Päijät-Häme CentralHospital, Lahti); Juhani Sivenius (Kuopio University Hospital, Kuo-pio). France: Pierre Amarenco (Bichat Hospital, Denis Diderot Uni-versity, Paris); Jacques Boulliat (Centre Hospitalier Fleyriat, Bourgen Bresse); Thomas de Broucker (Hôpital Delafontaine, St. Denis);François Chollet (Hôpital Purpan, Toulouse); Marie-Helene Ma-hagne (Hôpital Pasteur, Nice); Loic Milandre (Hôpital de la Timone,Marseille); Thierry Moulin (CHU-Hôpital Jean Minjoz, Besançon);Etienne Roullet (Hôpital Tenon, Paris). Germany: Ulrich Bogdahn(Universität Regensburg im Bezirksklinikum, Regensburg); OttoBusse (Klinikum Minden, Minden); H.C. Diener (Universitätsklini-kum Essen, Essen); Roman Haberl (Städtisches Krankenhaus Har-laching, München); Gerhard Hamann (Klinikum Großhadern,München); Lutz Harms (Neurologische Poliklinik der Charité, Ber-lin); Albrecht Hendrich, Germar Kroczek (Klinikum Rodach, BadRodach); Michael Hennerici (Klinikum Mannheim, Mannheim);Stefan Knecht, Henning Henningsen (Westfälische Wilhems-Uni-versität, Münster); Christoph Lichy, Armin Grau (Ruprecht-Karls-Universität Heidelberg, Heidelberg); Dirk Sander (Klinikum Rechtsder Isar, München); Dietmar Schneider, Jörg Berrouschot (Universi-tätsklinikum der Universität Leipzig, Leipzig). Greece: ClimentineKarageorgiou (General State Hospital of Athens ‘G Gennimatas’,Athens); Aristeidis Kazis (General Hospital ‘G Papanikolaou’, Thes-saloniki); Ioannis Mylonas (General Hospital A.H.E.P.A., Thessa-loniki); Pantelis Stathis (1st Therapeutic Institute of Social Security[IKA], Melissia, Athens); Dimitrios Vogiatzoglou (Amalia FlemingHospital, Melissia, Athens). Israel: Nathan Bornstein (Ichilov Hos-pital, Tel Aviv); Silvia Honigman, Bella Gross (Carmel Hospital,Haifa); Yair Lampl (Wolfson Medical Center, Holon); JonathanStreifler (Rabin Medical Center, Petach-Tikva). Italy: Antonio Ca-purso (Policlinico Universitario, Bari); Giancarlo Comi, Nicola Ca-nal (Ospedale S. Raffaele, Milano); Lodovico Frattola (Ospedale S.Gerardo, Monza); Carlo Gandolfo (Universita di Genova, Genova);Marco Poloni, Angelo Mamoli (Ospedali Riuniti de Bergamo, Berga-mo); Umberto Senin (Universita di Perugia, Perugia). Mexico:Ricardo Rangel Guerra (Hospital Universitario ‘Dr. Jose EleuterioGonzalez’, Monterrey Nuevo Leon). The Netherlands: Jacques H.A. de Keyser (University Hospital Groningen, Groningen); AdriaanM. Boon (Oosterscheldeziekenhuizen, Goes); Jacob A. Haas (Twen-92 Erratumteborg Ziekenhuis, Almelo); Daan J. Kamphuis (Reinier de GraafGasthuis, Delft); Paulus L. M. De Kort (St. Elisabeth Ziekenhuis,Tilburg); Peter J. Koudstaal (Erasmus Medisch Centrum, Rotter-dam). New Zealand: Neil E. Anderson (Auckland Hospital, Auck-land); Russell Scott (Christchurch Hospital, Christchurch); GagrathP. J. Singh (North Shore Hospital, Takapuna). Poland: Anna Czlon-kowska (Institute of Psychiatry and Neurology, Warszawa); WieslawDrozdowski (Bialystok Medical Academy, Bialystok); Zdzislaw Gra-lewski (Regional Woiewodeship Hospital, Sosnowiec); Wojciech Ko-zubski (Medical Academy Poznan, Poznan); Arleta Kuczynska-Zard-zewialy (Wolski Hospital, Warszawa) Ryszard Podemski (MedicalAcademy Wroclaw, Wroclaw); Zbigniew Stelmasiak (Lublin MedicalAcademy, Lublin); Andrzej Szczudlik (Jagiellonian University, Kra-kow). Portugal: Carlos Correia (Hospital Sto. Antonio, Porto); LuisCunha (Hospital da Universidade de Coimbra, Coimbra); José Ferro(Hospital de Santa Maria, Lisboa). Slovakia: Jan Lietava (ComeniusUniversity, Bratislava); Katarina Raslova (Metabolic Center, Bratis-lava). South Africa: Jonathan Carr (Tygerberg Hospital, Parow);John Gardiner (Constantia MediClinic, Cape Town); Abraham J.Kruger (Universitas Hospital, Bloemfontein). Spain: Angel Chamo-rro (Hospital Clinico, Barcelona); Antonio Dávalos (Hospital JosepTrueta, Girona); José Egido (Hospital Clinico San Carlos, Madrid);Oscar Fernandez (Hospital Carlos Haya, Malaga), José Ramón Gon-zález Marcos (Hospital Virgen del Rocio, Sevilla); Jordi Matias-Guiu (Hospital General de Alicante, Alicante); Dolores Jiménez(Hospital Universitario de Nuestra Señora de Valme, Sevilla); AidaLago (Hospital La Fe, Valencia); Carmen Jimenez Martinez (Hospi-tal Son Dureta, Palma de Mallorca); Enrique Mostacero (HospitalClinico Universitario Lozana Blesa, Zaragoza); Francisco Rubio(Ciudad Sanitaria Universitaria de Bellvitge, Barcelona); José Alva-rez Sabin (Hospital Vall d’Hebron, Barcelona); Exuperio Diez Teje-dor (Hospital la Paz, Madrid); Manuel González Torres (HospitalVirgen de la Macarena, Sevilla), José Trejo (Hospital General deYague, Burgos); José Vivancos (Hospital La Princesa, Madrid). Swe-den: Barbro Leijd (St. Görans Hospital, Stockholm); Ann CharlotteLaska, Thomas Leoo (Danderyds Hospital, Danderyd); Tage Strand(Norrlands Universitetssjukhus, Umea); Andreas Terent (Akademis-ka Hospital, Uppsala); Anna Wägner (Karolinska Sjukhuset, Stock-holm); Torbjorn Wallén (Västervik Hospital, Västervik). Switzer-land: Ralf Baumgartner (Universitätsspital Zürich, Zürich); JulienBogousslavsky (Centre Hospitalier Universitaire Vaudois, Lau-sanne); Hansjörg Hungerbühler (Kantonsspital Aarau (Aarau); Phi-lippe Lyrer (Neurologische Universitätsklinik, Basel); Heinrich Mat-tle (Neurologische Poliklinik Inselspital, Bern). United Kingdom:Philip Bath (Nottingham City Hospital, Nottingham); Enefioke B.Ekpo (Queen Elizabeth Hospital, Woolwich); Anne Freeman (St.Woolos Hospital, Newport); Kennedy R. Lees (Western Infirmary,Glasgow); Hamsaraj G.M. Shetty (University Hospital of Wales,Cardiff); Mary Joan MacLeod, Roelfe Dijkhuizen (Aberdeen RoyalInfirmary, Aberdeen); Ronald. S. MacWalter (Ninewells Hospital &Medical School, Dundee); Anil K. Sharma (University Hospital Ain-tree, Liverpool). USA: Gregory Albers (Stanford Stroke Center, PaloAlto, Calif.); Irfan Altafullah (Minneapolis Clinic of Neurology,Golden Valley, Minn.); Oscar Benavente (University of TexasHealth Science Center, San Antonio, Tex.); Diane Book (MedicalCollege of Wisconsin, Milwaukee, Wisc.); Joseph Broderick (Univer-sity of Cincinnati, Cincinnati, Ohio); Christopher Calder (UpstateClinical Research LLC, Albany, N.Y.); Alfred S. Callahan (Neuro-logic Consultants, P.C., Nashville, Tenn); Walter Carlini (MedfordNeurological Clinic, Medford, Oreg.); Seemant Chaturvedi (DetroitMedical Center, Detroit, Mich.); Thomas Chippendale (North Coun-ty Neurology Associates, Oceanside, Calif); Wayne Clark (OregonStroke Center, Portland, Oreg.); Bruce Coull (Arizona HealthSciences Center, Tucson, Ariz.); Patricia Davis (University of IowaHospitals and Clinics, Iowa City, Iowa); Thomas Devlin (Chattanoo-ga Neurology Associates, Chattanooga, Tenn.); Arthur R. Dick (Uni-versity of Kansas Medical Center, Kansas City, Kans.); GeorgeDooneief (The Neurology Group, P.C., Norristown, Pa.); R. ScottDuff (COX Pharmacotherapy Research Division, Springfield, Mo.);Nordeli Estronza, K. Alvin Lloyd (Blue Ridge Research Center, Roa-noke, Va.); Alejandro Forteza (University of Miami, Miami, Fla.);Michael R. Frankel, Terry Jacobson (Grady Health System, Atlanta,Ga.); James L. Frey (Barrow Neurology Clinics, Phoenix, Ariz.);Gary Friday (Bryn Mawr Hospital, Bryn Mawr, Pa.); Jerome Gold-stein (San Francisco Clinical Research Center, San Francisco, Calif.);Glenn Graham (VA Medical Center, Albuquerque, N.Mex.); MaximHammer, Steven Goldstein, James Gebel (University of PittsburghMedical Center, Pittsburgh, Pa.); Wayne Harper (Wake ResearchAssociates, Raleigh, N.C.); Subramanian Hariharan, Souvik Sen(New Jersey Neuroscience Institute, Edison, N.J.); Jonathan Harris(Neurologic Consultants, Fort Lauderdale, Fla.); Barry Hendin(Phoenix Neurological Associates, Phoenix, Ariz.); David C. Hess,(VA Medical Center, Augusta, Ga.); Richard Hinton (NeurologyConsultants, Dallas, Tex.); Joshua Hollander (Rochester GeneralHospital, Rochester, N.Y.); Richard L. Hughes (Denver GeneralHospital, Denver, Colo.); Scott Kasner (University of PennsylvaniaMedical Center, Philadelphia, Pa.); T.A. Kent (University of TexasMedical Division, Galveston, Tex.); Lance Kim (RENSTAR Medi-cal Research, Ocala, Fla.); Howard Kirshner (Vanderbilt UniversityMedical Center, Nashville, Tenn.); Marian LaMonte (University ofMaryland Medical Center, Baltimore, Md.); Lucy Y. Ledbetter (Neu-rology Center of Middle Tennessee, Columbia, Tenn.); KennethLevin (Neurology Group of Bergen County, Ridgewood, N.J.); Rich-ard Libman (Long Island Jewish Health Systems, New Hyde Park,N.Y.); John Matlock (San Antonio Preventive & Diagnostic Medi-cine, PA, San Antonio, Tex.); Paul McDowell (Private practice,Huntsville, Ala.); Francis E. McGee (Neurological Associates Inc.,Richmond, Va.); Brett Meyer, Christy Jackson (San Diego StrokeCenter, San Diego, Calif.); Alireza Minagar, Aurora Pajeau (LSUMedical Center, Shreveport, La.); Frederick E. Munschauer (BuffaloGeneral Hospital, Buffalo, N.Y.); Richard Munson (Evanston North-western Healthcare, Evanston, Ill.); Marshall Nash (Dekalb Neurolo-gy Associates, Decatur, Ga.); Abdullah Nassief, Chung Hsu (Wash-ington University School of Medicine, St. Louis, Mo.); Sean C. Orr,Roekchai Tulyapronchote, Camilio Gomez (Department of Neurolo-gy, Birmingham, Ala.); Gerald Ratinov (Christus St. Joseph MedicalPlace, Houston, Tex.); Virgilio Salanga, Bhuvaneswari K. Danda-pani (Cleveland Clinic Florida, Weston, Fla.); Scott Silliman (Uni-versity of Florida Health Sciences Center, Jacksonville, FL); RichardSinger (Neurology Clinical Research Inc., Plantation, Fla.); DonSmith (Colorado Neurological Institute Stroke Program, Englewood,Colo.); Herman Sullivan (Michigan Medical PC, Grand Rapids,Mich.); David Thaler (New England Medical Center, Boston, Mass.);Gretchen Tietjen (Medical College of Ohio, Toledo, Ohio); MichaelTuchman (Palm Beach Neurological Group, Palm Beach Gardens,Fla.); David Uskavitch (St. Thomas Medical Plaza, Nashville,Tenn.); Ralph Vicari (Melbourne Internal Medicine Associates, Mel-bourne, Fla.); Richard Weinstein (Diablo Clinical Research, WalnutCreek, Calif.); Janet Wilterdink (Rhode Island Hospital, Providence,R.I.); Richard Zweifler (USA Medical Center, Mobile, Ala.); PieroVerro (University of California-Davis, Sacramento, Calif.); MarilynRymer (Center for Clinical Neurological Studies, LC, Kansas City,Mo.). Venezuela: Mario de Bastos (Hospital Universitario de Cara-cas, Caracas).

Erratum: Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (Cerebrovascular Diseases (2003) 16 (389-395))

https://ir.lib.uwo.ca/cgi/viewcontent.cgi?article=1300&context=medpub

Erratum: Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study (Cerebrovascular Diseases (2003) 16 (389-395))

Abstract

Similar works

Full text

Available Versions

Scholarship@Western